All in the family: using inherited cancer syndromes to understand de-regulated cell signaling in brain tumors.
The cell signaling pathways that are tightly regulated during development are often co-opted by cancer cells to allow them to escape from the constraints that normally limit cell growth and cell movement. In this regard, de-regulated signaling in cancer cells confers a number of key tumor-associated properties, including increased cell proliferation, decreased cell death, and increased cell motility. The identification of some of these critical signaling pathways in the nervous system has come from studies of inherited cancer syndromes in which affected individuals develop brain tumors. The study of brain tumors arising in patients with neurofibromatosis 1 (NF1), neurofibromatosis 2 (NF2), and tuberous sclerosis complex (TSC) has already uncovered several key intracellular signaling pathways important for modulating brain tumor growth. An in-depth analysis of these intracellular signaling pathways will not only lead to an improved understanding of the process of brain tumorigenesis, but may also provide important molecular targets for future therapeutic drug design.
Houshmandi
S Sean
SS
Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Gutmann
David H
DH
D001932:Brain Neoplasms / Q000209:etiology* / Q000473:pathology; D006801:Humans; D009386:Neoplastic Syndromes, Hereditary / Q000473:pathology*; D009420:Nervous System / Q000473:pathology; D017253:Neurofibromatoses / Q000473:pathology; D015398:Signal Transduction; D014402:Tuberous Sclerosis / Q000473:pathology